{"gene":"HEXIM2","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2005,"finding":"HEXIM2, like HEXIM1, associates with 7SK snRNA and P-TEFb to form an inactive complex; in conjunction with 7SK, HEXIM2 inhibits P-TEFb kinase activity. When HEXIM1 is knocked down, HEXIM2 functionally compensates to maintain P-TEFb inhibition.","method":"Glycerol gradient analysis, immunoprecipitation, EMSA, in vitro kinase assay, siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (EMSA, kinase assay, IP, gradient sedimentation) in a single study, replicated independently by two labs same year","pmids":["15713662","15713661"],"is_preprint":false},{"year":2005,"finding":"HEXIM1 and HEXIM2 form stable homo- and hetero-oligomers (dimers) mediated by their C-terminal domains, and this multimeric state is maintained within the P-TEFb·HEXIM·7SK complex.","method":"Yeast two-hybrid, transfection assays, glycerol gradient ultracentrifugation, gel-permeation chromatography, chemical cross-linking","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biophysical methods plus two-hybrid, replicated across labs","pmids":["15994294","15713661","15965233"],"is_preprint":false},{"year":2005,"finding":"The large inactive P-TEFb complex contains a dimer of HEXIM1 or HEXIM2, one 7SK RNA molecule, and two P-TEFb molecules. The first 172 nucleotides of 7SK are sufficient to bind HEXIM2 and recruit/inhibit P-TEFb.","method":"Mutational analysis, glycerol gradient sedimentation, immunoprecipitation, stoichiometric analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — rigorous stoichiometric and mutational dissection with multiple methods","pmids":["15965233"],"is_preprint":false},{"year":2005,"finding":"HEXIM2 co-expression inhibits HIV Tat transactivation, paralleling HEXIM1, consistent with HEXIM2 sequestering P-TEFb away from Tat.","method":"Transfection/co-expression assay, reporter gene assay","journal":"Retrovirology","confidence":"Medium","confidence_rationale":"Tier 3 — single functional assay; mechanism inferred through P-TEFb inhibition context","pmids":["15992410"],"is_preprint":false},{"year":2007,"finding":"P-TEFb is inactivated upon binding to HEXIM2 (or HEXIM1) proteins associated with 7SK; dissociation of this complex occurs upon transcription inhibition and is facilitated by hnRNPs A1, A2, Q, and R binding to 7SK RNA.","method":"Immunoprecipitation of 7SK-associated proteins, siRNA knockdown of hnRNPs, glycerol gradient sedimentation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal IP and functional siRNA knockdown, single lab","pmids":["17709395"],"is_preprint":false},{"year":2009,"finding":"Hexim2 binds Cyclin T2 with higher affinity than Cyclin T1 (and conversely Hexim1 prefers Cyclin T1), and both Hexim1 and Hexim2 interact with importin alpha (Kd ~0.5 µM for Hexim2 vs ~2.0 µM for Hexim1), suggesting a collaborative nuclear import pathway for Cyclin T via Hexim proteins.","method":"Isothermal titration calorimetry (ITC), electrophoretic mobility shift assay (EMSA) with radiolabeled 7SK snRNA","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — quantitative binding measurements by ITC and EMSA with defined affinities, single rigorous study","pmids":["19883659"],"is_preprint":false},{"year":2014,"finding":"Release of P-TEFb from the 7SK snRNP (containing HEXIM1 or HEXIM2) leads to increased transcription of HEXIM1 (but not HEXIM2) from a proximal promoter, indicating a feedback loop that maintains P-TEFb equilibrium.","method":"ChIP-seq, luciferase reporter assay, siRNA knockdown of superelongation complex components (AFF4, ELL2)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq plus functional reporters, distinguishes HEXIM1 vs HEXIM2 regulation; single lab","pmids":["24515107"],"is_preprint":false}],"current_model":"HEXIM2 is a paralogue of HEXIM1 that binds 7SK snRNA and, as part of a dimer (homo- or hetero-dimer with HEXIM1), assembles a large inactive complex containing two P-TEFb molecules, thereby inhibiting CDK9 kinase activity; it preferentially associates with Cyclin T2 over Cyclin T1, interacts with importin alpha to facilitate nuclear import of Cyclin T, and functionally compensates for HEXIM1 loss to maintain cellular P-TEFb homeostasis."},"narrative":{"teleology":[{"year":2005,"claim":"Identification of HEXIM2 as a second 7SK-binding P-TEFb inhibitor established that P-TEFb regulation is not solely dependent on HEXIM1 and revealed built-in redundancy in CDK9 control.","evidence":"Glycerol gradient, IP, EMSA, in vitro kinase assay, and siRNA knockdown in human cell lines by two independent groups","pmids":["15713662","15713661"],"confidence":"High","gaps":["Structural basis for how HEXIM2 contacts CDK9 was not resolved","Tissue-specific expression differences between HEXIM1 and HEXIM2 not addressed","No in vivo (animal model) confirmation of compensatory relationship"]},{"year":2005,"claim":"Determination that HEXIM1 and HEXIM2 form homo- and heterodimers via C-terminal domains, and that the large 7SK snRNP contains one HEXIM dimer, one 7SK molecule, and two P-TEFb units, defined the stoichiometry of the inactive complex.","evidence":"Yeast two-hybrid, gel-permeation chromatography, chemical cross-linking, glycerol gradient sedimentation, and mutational analysis","pmids":["15994294","15965233"],"confidence":"High","gaps":["Relative abundance of HEXIM2 homodimers versus heterodimers in cells was not quantified","No high-resolution structure of the full complex","Mechanism by which dimerization is required for P-TEFb inhibition not established"]},{"year":2007,"claim":"Discovery that hnRNP proteins (A1, A2, Q, R) bind 7SK RNA and facilitate dissociation of the HEXIM–P-TEFb complex revealed the release mechanism that reactivates P-TEFb upon transcription stress.","evidence":"IP of 7SK-associated proteins, siRNA knockdown of hnRNPs, glycerol gradient sedimentation in human cells","pmids":["17709395"],"confidence":"Medium","gaps":["Whether hnRNPs preferentially displace HEXIM2- versus HEXIM1-containing complexes was not tested","Signal transduction pathway linking transcription inhibition to hnRNP engagement of 7SK is unknown"]},{"year":2009,"claim":"Quantitative binding measurements revealed HEXIM2 preferentially binds Cyclin T2 and importin alpha with higher affinity than HEXIM1, suggesting paralog-specific P-TEFb subunit selectivity and a role in nuclear import of Cyclin T.","evidence":"Isothermal titration calorimetry and EMSA with purified recombinant proteins","pmids":["19883659"],"confidence":"High","gaps":["Functional consequence of Cyclin T2 preference for gene-specific transcription was not tested","In vivo validation of importin alpha-mediated Cyclin T nuclear import via HEXIM2 is lacking"]},{"year":2014,"claim":"Demonstration that P-TEFb release selectively upregulates HEXIM1 but not HEXIM2 transcription uncovered an asymmetric feedback loop, implying that HEXIM2 levels are regulated independently of P-TEFb activity.","evidence":"ChIP-seq, luciferase reporter assays, and siRNA knockdown of super elongation complex components in human cells","pmids":["24515107"],"confidence":"Medium","gaps":["Transcriptional regulators of HEXIM2 expression remain unidentified","Physiological contexts in which HEXIM2-specific regulation becomes critical are unknown"]},{"year":null,"claim":"Open question: what are the non-redundant physiological roles of HEXIM2 versus HEXIM1, particularly given HEXIM2's Cyclin T2 preference and distinct transcriptional regulation?","evidence":"","pmids":[],"confidence":"Low","gaps":["No Hexim2 knockout animal model phenotype reported in the timeline","No genome-wide identification of genes specifically regulated by HEXIM2-containing 7SK complexes","High-resolution structure of HEXIM2 in complex with 7SK and P-TEFb is unavailable"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2,3]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,2,5]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]}],"pathway":[],"complexes":["7SK snRNP","P-TEFb·HEXIM·7SK complex"],"partners":["HEXIM1","CDK9","CCNT2","CCNT1","KPNA2"],"other_free_text":[]},"mechanistic_narrative":"HEXIM2 is a paralog of HEXIM1 that, together with 7SK snRNA, assembles into a large ribonucleoprotein complex containing a HEXIM dimer (homodimer or HEXIM1–HEXIM2 heterodimer) and two P-TEFb (CDK9–Cyclin T) molecules, thereby sequestering P-TEFb in an inactive state and inhibiting CDK9 kinase activity [PMID:15713662, PMID:15965233]. HEXIM2 preferentially associates with Cyclin T2 over Cyclin T1 and binds importin alpha with higher affinity than HEXIM1, implicating it in the nuclear import of Cyclin T subunits [PMID:19883659]. When HEXIM1 is depleted, HEXIM2 functionally compensates to maintain P-TEFb inhibition, although transcriptional feedback selectively upregulates HEXIM1 but not HEXIM2, indicating non-redundant regulatory wiring despite overlapping biochemical function [PMID:15713662, PMID:24515107]."},"prefetch_data":{"uniprot":{"accession":"Q96MH2","full_name":"Protein HEXIM2","aliases":["Hexamethylene bis-acetamide-inducible protein 2"],"length_aa":286,"mass_kda":32.4,"function":"Transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor (PubMed:15713661, PubMed:15713662). Core component of the 7SK RNP complex: in cooperation with 7SK snRNA sequesters P-TEFb in a large inactive 7SK snRNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (PubMed:15713661, PubMed:15713662)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96MH2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HEXIM2","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CDK9","stoichiometry":0.2},{"gene":"CSNK2B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HEXIM2","total_profiled":1310},"omim":[{"mim_id":"615695","title":"HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 2; HEXIM2","url":"https://www.omim.org/entry/615695"},{"mim_id":"607328","title":"HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1; HEXIM1","url":"https://www.omim.org/entry/607328"},{"mim_id":"606515","title":"RNA, 7SK, SMALL NUCLEAR; RN7SK","url":"https://www.omim.org/entry/606515"},{"mim_id":"603251","title":"CYCLIN-DEPENDENT KINASE 9; CDK9","url":"https://www.omim.org/entry/603251"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear speckles","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":43.5},{"tissue":"testis","ntpm":32.3}],"url":"https://www.proteinatlas.org/search/HEXIM2"},"hgnc":{"alias_symbol":["FLJ32384"],"prev_symbol":[]},"alphafold":{"accession":"Q96MH2","domains":[{"cath_id":"1.20.5","chopping":"108-140","consensus_level":"medium","plddt":91.5818,"start":108,"end":140},{"cath_id":"1.20.5","chopping":"223-281","consensus_level":"medium","plddt":88.9988,"start":223,"end":281}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96MH2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96MH2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96MH2-F1-predicted_aligned_error_v6.png","plddt_mean":70.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HEXIM2","jax_strain_url":"https://www.jax.org/strain/search?query=HEXIM2"},"sequence":{"accession":"Q96MH2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96MH2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96MH2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96MH2"}},"corpus_meta":[{"pmid":"15965233","id":"PMC_15965233","title":"Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15965233","citation_count":183,"is_preprint":false},{"pmid":"21853533","id":"PMC_21853533","title":"7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription.","date":"2011","source":"Wiley interdisciplinary reviews. RNA","url":"https://pubmed.ncbi.nlm.nih.gov/21853533","citation_count":147,"is_preprint":false},{"pmid":"17576689","id":"PMC_17576689","title":"Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17576689","citation_count":132,"is_preprint":false},{"pmid":"15713662","id":"PMC_15713662","title":"HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15713662","citation_count":102,"is_preprint":false},{"pmid":"17709395","id":"PMC_17709395","title":"The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17709395","citation_count":93,"is_preprint":false},{"pmid":"15713661","id":"PMC_15713661","title":"Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive positive transcription elongation factor b complexes for control of transcription.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15713661","citation_count":89,"is_preprint":false},{"pmid":"15994294","id":"PMC_15994294","title":"Transcription-dependent association of multiple positive transcription elongation factor units to a HEXIM multimer.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15994294","citation_count":50,"is_preprint":false},{"pmid":"24515107","id":"PMC_24515107","title":"Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24515107","citation_count":48,"is_preprint":false},{"pmid":"17395637","id":"PMC_17395637","title":"HEXIM1 is a promiscuous double-stranded RNA-binding protein and interacts with RNAs in addition to 7SK in cultured cells.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17395637","citation_count":43,"is_preprint":false},{"pmid":"15992410","id":"PMC_15992410","title":"Inhibition of Tat activity by the HEXIM1 protein.","date":"2005","source":"Retrovirology","url":"https://pubmed.ncbi.nlm.nih.gov/15992410","citation_count":34,"is_preprint":false},{"pmid":"16152622","id":"PMC_16152622","title":"siRNA depletion of 7SK snRNA induces apoptosis but does not affect expression of the HIV-1 LTR or P-TEFb-dependent cellular genes.","date":"2005","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16152622","citation_count":31,"is_preprint":false},{"pmid":"19883659","id":"PMC_19883659","title":"Specificity of Hexim1 and Hexim2 complex formation with cyclin T1/T2, importin alpha and 7SK snRNA.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19883659","citation_count":26,"is_preprint":false},{"pmid":"34482648","id":"PMC_34482648","title":"Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.","date":"2021","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34482648","citation_count":22,"is_preprint":false},{"pmid":"40026415","id":"PMC_40026415","title":"Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis.","date":"2025","source":"Cardiovascular therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/40026415","citation_count":6,"is_preprint":false},{"pmid":"37111415","id":"PMC_37111415","title":"Study of the Genetic Expression of Antiretroviral Restriction Factors and Acute Phase Proteins in Cattle Infected with Bovine Leukemia Virus.","date":"2023","source":"Pathogens (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/37111415","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9105,"output_tokens":1618,"usd":0.025792},"stage2":{"model":"claude-opus-4-6","input_tokens":4898,"output_tokens":1738,"usd":0.10191},"total_usd":0.127702,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM2, like HEXIM1, associates with 7SK snRNA and P-TEFb to form an inactive complex; in conjunction with 7SK, HEXIM2 inhibits P-TEFb kinase activity. When HEXIM1 is knocked down, HEXIM2 functionally compensates to maintain P-TEFb inhibition.\",\n      \"method\": \"Glycerol gradient analysis, immunoprecipitation, EMSA, in vitro kinase assay, siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (EMSA, kinase assay, IP, gradient sedimentation) in a single study, replicated independently by two labs same year\",\n      \"pmids\": [\"15713662\", \"15713661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM1 and HEXIM2 form stable homo- and hetero-oligomers (dimers) mediated by their C-terminal domains, and this multimeric state is maintained within the P-TEFb·HEXIM·7SK complex.\",\n      \"method\": \"Yeast two-hybrid, transfection assays, glycerol gradient ultracentrifugation, gel-permeation chromatography, chemical cross-linking\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biophysical methods plus two-hybrid, replicated across labs\",\n      \"pmids\": [\"15994294\", \"15713661\", \"15965233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The large inactive P-TEFb complex contains a dimer of HEXIM1 or HEXIM2, one 7SK RNA molecule, and two P-TEFb molecules. The first 172 nucleotides of 7SK are sufficient to bind HEXIM2 and recruit/inhibit P-TEFb.\",\n      \"method\": \"Mutational analysis, glycerol gradient sedimentation, immunoprecipitation, stoichiometric analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — rigorous stoichiometric and mutational dissection with multiple methods\",\n      \"pmids\": [\"15965233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM2 co-expression inhibits HIV Tat transactivation, paralleling HEXIM1, consistent with HEXIM2 sequestering P-TEFb away from Tat.\",\n      \"method\": \"Transfection/co-expression assay, reporter gene assay\",\n      \"journal\": \"Retrovirology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single functional assay; mechanism inferred through P-TEFb inhibition context\",\n      \"pmids\": [\"15992410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"P-TEFb is inactivated upon binding to HEXIM2 (or HEXIM1) proteins associated with 7SK; dissociation of this complex occurs upon transcription inhibition and is facilitated by hnRNPs A1, A2, Q, and R binding to 7SK RNA.\",\n      \"method\": \"Immunoprecipitation of 7SK-associated proteins, siRNA knockdown of hnRNPs, glycerol gradient sedimentation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal IP and functional siRNA knockdown, single lab\",\n      \"pmids\": [\"17709395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hexim2 binds Cyclin T2 with higher affinity than Cyclin T1 (and conversely Hexim1 prefers Cyclin T1), and both Hexim1 and Hexim2 interact with importin alpha (Kd ~0.5 µM for Hexim2 vs ~2.0 µM for Hexim1), suggesting a collaborative nuclear import pathway for Cyclin T via Hexim proteins.\",\n      \"method\": \"Isothermal titration calorimetry (ITC), electrophoretic mobility shift assay (EMSA) with radiolabeled 7SK snRNA\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative binding measurements by ITC and EMSA with defined affinities, single rigorous study\",\n      \"pmids\": [\"19883659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Release of P-TEFb from the 7SK snRNP (containing HEXIM1 or HEXIM2) leads to increased transcription of HEXIM1 (but not HEXIM2) from a proximal promoter, indicating a feedback loop that maintains P-TEFb equilibrium.\",\n      \"method\": \"ChIP-seq, luciferase reporter assay, siRNA knockdown of superelongation complex components (AFF4, ELL2)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus functional reporters, distinguishes HEXIM1 vs HEXIM2 regulation; single lab\",\n      \"pmids\": [\"24515107\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HEXIM2 is a paralogue of HEXIM1 that binds 7SK snRNA and, as part of a dimer (homo- or hetero-dimer with HEXIM1), assembles a large inactive complex containing two P-TEFb molecules, thereby inhibiting CDK9 kinase activity; it preferentially associates with Cyclin T2 over Cyclin T1, interacts with importin alpha to facilitate nuclear import of Cyclin T, and functionally compensates for HEXIM1 loss to maintain cellular P-TEFb homeostasis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HEXIM2 is a paralog of HEXIM1 that, together with 7SK snRNA, assembles into a large ribonucleoprotein complex containing a HEXIM dimer (homodimer or HEXIM1–HEXIM2 heterodimer) and two P-TEFb (CDK9–Cyclin T) molecules, thereby sequestering P-TEFb in an inactive state and inhibiting CDK9 kinase activity [PMID:15713662, PMID:15965233]. HEXIM2 preferentially associates with Cyclin T2 over Cyclin T1 and binds importin alpha with higher affinity than HEXIM1, implicating it in the nuclear import of Cyclin T subunits [PMID:19883659]. When HEXIM1 is depleted, HEXIM2 functionally compensates to maintain P-TEFb inhibition, although transcriptional feedback selectively upregulates HEXIM1 but not HEXIM2, indicating non-redundant regulatory wiring despite overlapping biochemical function [PMID:15713662, PMID:24515107].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of HEXIM2 as a second 7SK-binding P-TEFb inhibitor established that P-TEFb regulation is not solely dependent on HEXIM1 and revealed built-in redundancy in CDK9 control.\",\n      \"evidence\": \"Glycerol gradient, IP, EMSA, in vitro kinase assay, and siRNA knockdown in human cell lines by two independent groups\",\n      \"pmids\": [\"15713662\", \"15713661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how HEXIM2 contacts CDK9 was not resolved\",\n        \"Tissue-specific expression differences between HEXIM1 and HEXIM2 not addressed\",\n        \"No in vivo (animal model) confirmation of compensatory relationship\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Determination that HEXIM1 and HEXIM2 form homo- and heterodimers via C-terminal domains, and that the large 7SK snRNP contains one HEXIM dimer, one 7SK molecule, and two P-TEFb units, defined the stoichiometry of the inactive complex.\",\n      \"evidence\": \"Yeast two-hybrid, gel-permeation chromatography, chemical cross-linking, glycerol gradient sedimentation, and mutational analysis\",\n      \"pmids\": [\"15994294\", \"15965233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relative abundance of HEXIM2 homodimers versus heterodimers in cells was not quantified\",\n        \"No high-resolution structure of the full complex\",\n        \"Mechanism by which dimerization is required for P-TEFb inhibition not established\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that hnRNP proteins (A1, A2, Q, R) bind 7SK RNA and facilitate dissociation of the HEXIM–P-TEFb complex revealed the release mechanism that reactivates P-TEFb upon transcription stress.\",\n      \"evidence\": \"IP of 7SK-associated proteins, siRNA knockdown of hnRNPs, glycerol gradient sedimentation in human cells\",\n      \"pmids\": [\"17709395\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether hnRNPs preferentially displace HEXIM2- versus HEXIM1-containing complexes was not tested\",\n        \"Signal transduction pathway linking transcription inhibition to hnRNP engagement of 7SK is unknown\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Quantitative binding measurements revealed HEXIM2 preferentially binds Cyclin T2 and importin alpha with higher affinity than HEXIM1, suggesting paralog-specific P-TEFb subunit selectivity and a role in nuclear import of Cyclin T.\",\n      \"evidence\": \"Isothermal titration calorimetry and EMSA with purified recombinant proteins\",\n      \"pmids\": [\"19883659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional consequence of Cyclin T2 preference for gene-specific transcription was not tested\",\n        \"In vivo validation of importin alpha-mediated Cyclin T nuclear import via HEXIM2 is lacking\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstration that P-TEFb release selectively upregulates HEXIM1 but not HEXIM2 transcription uncovered an asymmetric feedback loop, implying that HEXIM2 levels are regulated independently of P-TEFb activity.\",\n      \"evidence\": \"ChIP-seq, luciferase reporter assays, and siRNA knockdown of super elongation complex components in human cells\",\n      \"pmids\": [\"24515107\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Transcriptional regulators of HEXIM2 expression remain unidentified\",\n        \"Physiological contexts in which HEXIM2-specific regulation becomes critical are unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Open question: what are the non-redundant physiological roles of HEXIM2 versus HEXIM1, particularly given HEXIM2's Cyclin T2 preference and distinct transcriptional regulation?\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No Hexim2 knockout animal model phenotype reported in the timeline\",\n        \"No genome-wide identification of genes specifically regulated by HEXIM2-containing 7SK complexes\",\n        \"High-resolution structure of HEXIM2 in complex with 7SK and P-TEFb is unavailable\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 4, 6]}\n    ],\n    \"complexes\": [\n      \"7SK snRNP\",\n      \"P-TEFb·HEXIM·7SK complex\"\n    ],\n    \"partners\": [\n      \"HEXIM1\",\n      \"CDK9\",\n      \"CCNT2\",\n      \"CCNT1\",\n      \"KPNA2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}